Former Government chief scientific adviser, David King, writes eloquently on the Nature blog today about his concerns over the cuts in science funding announced last week.
UPDATE The full spending review document can be seen here. Note the very explicit reference and commitment to the Medical Research Council (MRC) including expenditure growth in real terms (p52). We have just had a message through from NIHR which repeats the spending review document messages and is heavy on language about pulling through the … Continue reading CSR – AMRC reaction on science settlement
Well, we won't have too long to wait to know whether this is true but the Guardian is reporting this evening that science spending is to be frozen in tomorrow's CSR for a review period, representing a 10% reduction in real terms over that time as inflation reduces the spending power of departments. ...and further … Continue reading CSR press reports: science spending to be 'frozen'
We are packing up. No, no, no, not in that sense. It is just that we are moving office in a few weeks. I am ashamed to say that I am the last of our team to begin the task of separating the recently aquired detritus from the must-keep documents that tell something of our history. … Continue reading CSR and painting by numbers
I spoke at an interesting event last week organised by OneNucleus, a membership organisation which brings together international life science and healthcare companies. The audience was packed with representatives of both large and small companies including many biotechs. It was the day before Vince Cable's speech and much concern about what he would or would not … Continue reading Venture capitalists weigh in on science funding debate